<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>(J Dermatol[TA])</title><link>http://www.unboundmedicine.com/medline//journal/J_Dermatol</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Alopecia areata possibly induced by autoimmune reaction in a patient with human T-cell lymphotropic virus-1-associated myelopathy.</title><link>http://www.unboundmedicine.com/medline/citation/23668541/Alopecia_areata_possibly_induced_by_autoimmune_reaction_in_a_patient_with_human_T_cell_lymphotropic_virus_1_associated_myelopathy_</link><description><div class="result"><ul><li class="author">Ito T, Shimada S, Mori T, et al. </li><li class="title"><a href="./citation/23668541/Alopecia_areata_possibly_induced_by_autoimmune_reaction_in_a_patient_with_human_T_cell_lymphotropic_virus_1_associated_myelopathy_">Alopecia areata possibly induced by autoimmune reaction in a patient with human T-cell lymphotropic virus-1-associated myelopathy.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May; 40(5):399-401.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12128">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">A 38-year-old female patient suffered from alopecia areata totalis followed by human T-cell lymphotropic virus-1-associated myelopathy (HAM). These two diseases have recently been considered to be related to cell-mediated autoimmune reactions. Immunohistochemistry revealed accumulation of CXCR3(+) CD8(+) T cells around hair bulbs in alopecic lesions. Furthermore, flow cytometric analysis showed the elevated frequency of CD8(+) human leukocyte antigen DR(+) -activated T cells at the initial time and declined at the hair regrowth phase with HAM. CD4(+) CD25(+) adult T-cell leukemia/lymphoma cells were elevated at hair loss phase and decreased after improvement of hair loss. These results suggest that autoreactive and cytotoxic CD8(+) T cells induce not only alopecia areata but also HAM in ATL patients. This case highlights that the autoimmune reactions may play an important role in the pathogenesis of alopecia areata and HAM.</div></div></div></description></item><item><title>Hypopigmentation in Hermansky-Pudlak syndrome.</title><link>http://www.unboundmedicine.com/medline/citation/23668540/Hypopigmentation_in_Hermansky_Pudlak_syndrome_</link><description><div class="result"><ul><li class="author">Wei AH, He X, Li W </li><li class="title"><a href="./citation/23668540/Hypopigmentation_in_Hermansky_Pudlak_syndrome_">Hypopigmentation in Hermansky-Pudlak syndrome.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May; 40(5):325-9.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12025">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, bleeding tendency, and ceroid deposition which often leads to death in midlife. Currently, nine genes have been identified as causative for HPS in humans. Hypopigmentation is the prominent feature of HPS, attributable to the disrupted biogenesis of melanosome, a member of the lysosome-related organelle (LRO) family. Current understanding of the cargo transporting mechanisms into the melanosomes expands our knowledge of the pathogenesis of hypopigmentation in HPS patients.</div></div></div></description></item><item><title>Albinism in europe.</title><link>http://www.unboundmedicine.com/medline/citation/23668539/Albinism_in_europe_</link><description><div class="result"><ul><li class="author">Mártinez-García M, Montoliu L </li><li class="title"><a href="./citation/23668539/Albinism_in_europe_">Albinism in europe.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May; 40(5):319-24.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12170">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Albinism is a rare genetic condition associated with a variable hypopigmentation phenotype, which can affect the pigmentation of only the eyes or both the eyes and the skin/hair, resulting in ocular (OA) or oculocutaneous albinism (OCA), respectively. At least four forms of OCA and one of OA are known, associated with TYR (OCA1), OCA2 (OCA2), TYRP1 (OCA3), SLC45A2 (OCA4) and GPR143 (OA1) loci, respectively. Additionally, the rarest syndromic forms of albinism, affecting the normal function of other organs, can be grouped in Hermansky-Pudlak syndrome (HPS1-9) and the Chediak-Higashi syndrome (CHS1). In summary, a total of 15 genes are currently associated with various types of albinism. However, new genes have been recently described, associated with autosomal recessive oculocutaneous albinism with highly similar phenotypes but diverse molecular origin, indicating that there are likely to be more than 15 genes whose mutations will be associated with albinism. In this review, we will describe the different types of albinism and comment on its prevalence in European countries. Some preclinical attempts for innovative therapeutic approaches of different types of albinism will be also discussed.</div></div></div></description></item><item><title>Modern vitiligo genetics sheds new light on an ancient disease.</title><link>http://www.unboundmedicine.com/medline/citation/23668538/Modern_vitiligo_genetics_sheds_new_light_on_an_ancient_disease_</link><description><div class="result"><ul><li class="author">Spritz RA </li><li class="title"><a href="./citation/23668538/Modern_vitiligo_genetics_sheds_new_light_on_an_ancient_disease_">Modern vitiligo genetics sheds new light on an ancient disease.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May; 40(5):310-8.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12147">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Vitiligo is a complex disorder in which autoimmune destruction of melanocytes results in white patches of skin and overlying hair. Over the past several years, extensive genetic studies have outlined a biological framework of vitiligo pathobiology that underscores its relationship to other autoimmune diseases. This biological framework offers insight into both vitiligo pathogenesis and perhaps avenues towards more effective approaches to treatment and even disease prevention.</div></div></div></description></item><item><title>Genetics of hypopigmentary disorders.</title><link>http://www.unboundmedicine.com/medline/citation/23668537/Genetics_of_hypopigmentary_disorders_</link><description><div class="result"><ul><li class="title"><a href="./citation/23668537/Genetics_of_hypopigmentary_disorders_">Genetics of hypopigmentary disorders.<span class="title-pubtype"> [Editorial]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May; 40(5):309.</li><li class="links"><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12172">Publisher Full Text</span></li></ul></div></description></item><item><title>Case of epidermal cyst on the glans penis.</title><link>http://www.unboundmedicine.com/medline/citation/23663242/Case_of_epidermal_cyst_on_the_glans_penis_</link><description><div class="result"><ul><li class="author">Nobeyama Y, Nakagawa H </li><li class="title"><a href="./citation/23663242/Case_of_epidermal_cyst_on_the_glans_penis_">Case of epidermal cyst on the glans penis.<span class="title-pubtype"> [LETTER]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May 10.</li><li class="links"><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12176">Publisher Full Text</span></li></ul></div></description></item><item><title>Epidermolysis bullosa pruriginosa triggered by scabies infestation.</title><link>http://www.unboundmedicine.com/medline/citation/23663219/Epidermolysis_bullosa_pruriginosa_triggered_by_scabies_infestation_</link><description><div class="result"><ul><li class="author">Kim J, Loh CH, Murrell DF </li><li class="title"><a href="./citation/23663219/Epidermolysis_bullosa_pruriginosa_triggered_by_scabies_infestation_">Epidermolysis bullosa pruriginosa triggered by scabies infestation.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May 10.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12167">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Epidermolysis bullosa pruriginosa (EB-Pr) is an unusual variant of dystrophic EB. Potential genetic disease modifiers and metabolic factors have been investigated, but thus far no specific insight into this phenotype has emerged. We report an in-depth description of three patients diagnosed as having EB-Pr in whom this particular phenotype developed after scabies infestation and dramatically improved after full treatment. This short communication suggests that scabies infestation could be one of the important triggering factors for the development of the EB-Pr phenotype.</div></div></div></description></item><item><title>Association between MEFV gene mutations and recurrent aphthous stomatitis in a cohort of Turkish patients.</title><link>http://www.unboundmedicine.com/medline/citation/23663176/Association_between_MEFV_gene_mutations_and_recurrent_aphthous_stomatitis_in_a_cohort_of_Turkish_patients_</link><description><div class="result"><ul><li class="author">Kalkan G, Yigit S, Karakus N, et al. </li><li class="title"><a href="./citation/23663176/Association_between_MEFV_gene_mutations_and_recurrent_aphthous_stomatitis_in_a_cohort_of_Turkish_patients_">Association between MEFV gene mutations and recurrent aphthous stomatitis in a cohort of Turkish patients.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May 10.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12159">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Recurrent aphthous stomatitis (RAS) has a multifactorial etiopathogenesis, an interaction between predisposing factors and/or systemic conditions and immunological components in genetically predisposed subjects. The Mediterranean fever (MEFV) gene has already been identified as being responsible for familial Mediterranean fever. Because the association between MEFV gene mutations and Behçet's disease has been reported before in several studies, we considered that the role of MEFV gene mutations should be studied in patients with RAS, because of the clinical similarities of both diseases. The aim of this study was to explore the frequency and clinical significance of MEFV gene mutations in a cohort of Turkish patients with RAS. The study population comprised 100 unrelated patients with a clinical diagnosis of RAS and 156 healthy controls. Genomic DNA was isolated and genotyped using polymerase chain reaction and restriction fragment length polymorphism for the four MEFV gene mutations (M694V, M680I, V726A and E148Q). There were statistically significant differences of the MEFV gene mutation carrier rates and allele frequencies between RAS patients and healthy controls (P = 0.042, odds ratio [OR] = 1.9, 95% confidence interval [CI] = 1.01-3.41; and P = 0.039, OR = 1.8, 95% CI = 1.02-3.14, respectively). Even if it is not statistically significant, the E148Q allele frequency was higher in patients with RAS than the control group. A statistically significant increased prevalence of MEFV variants in RAS patients was found. This is the first study to report that missense mutations of MEFV is associated with RAS in the Turkish population.</div></div></div></description></item><item><title>Case of diffuse cutaneous systemic sclerosis with anti-Ku and anti-centromere antibodies.</title><link>http://www.unboundmedicine.com/medline/citation/23663134/Case_of_diffuse_cutaneous_systemic_sclerosis_with_anti_Ku_and_anti_centromere_antibodies_</link><description><div class="result"><ul><li class="author">Ohashi S, Ueda-Hayakawa I, Isei T, et al. </li><li class="title"><a href="./citation/23663134/Case_of_diffuse_cutaneous_systemic_sclerosis_with_anti_Ku_and_anti_centromere_antibodies_">Case of diffuse cutaneous systemic sclerosis with anti-Ku and anti-centromere antibodies.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May 10.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12148">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">We report the case of a 58-year-old man who had an ulcer on the right middle finger that was cured by surgery 4 years before consultation with our department. A few years after the surgery, he noticed recurrence of the ulcer and sclerosis of the skin. At the initial examination, skin sclerosis was observed from the fingers to the upper arms and from the feet to the thighs. Pitting scars on the fingertips and punctured hemorrhages of the nail-fold capillaries were also present. Gastroscopy showed slight reflex esophagitis. Laboratory findings were positive for antinuclear antibody (ANA; 1:640) with a speckled and discrete speckled pattern. Anti-topoisomerase I (anti-topo I) antibody and anti-RNA polymerase III were negative, but anti-centromere antibody was positive in an enzyme-linked immunosorbent assay. Anti-Ku antibody was positive in an immunoprecipitation assay using extracts of the leukemia cell line K562. Therefore, the patient was diagnosed with diffuse cutaneous systemic sclerosis with anti-Ku and anti-centromere antibodies. Treatment with an oral antiplatelet agent, vitamin E, a proton pump inhibitor, and i.v. lipoprostaglandin E1 were started. Subsequently, there has been repeated recurrence of finger ulcers, but no muscle involvement has been detected since his first visit. This is the first reported case of systemic sclerosis with anti-Ku and anti-centromere antibodies.</div></div></div></description></item><item><title>Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor.</title><link>http://www.unboundmedicine.com/medline/citation/23663102/Case_report_of_anti_transcription_intermediary_factor_1_γ/α_antibody_positive_dermatomyositis_associated_with_gastric_cancer_and_immunoglobulin_G4_positive_pulmonary_inflammatory_pseudotumor_</link><description><div class="result"><ul><li class="author">Ito K, Imafuku S, Hamaguchi Y, et al. </li><li class="title"><a href="./citation/23663102/Case_report_of_anti_transcription_intermediary_factor_1_γ/α_antibody_positive_dermatomyositis_associated_with_gastric_cancer_and_immunoglobulin_G4_positive_pulmonary_inflammatory_pseudotumor_">Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="The Journal of dermatology">J Dermatol 2013 May 10.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1111/1346-8138.12141">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Dermatomyositis is a rare connective tissue disease often associated with internal malignancy and interstitial pneumonitis. Serologically, various auto-antibodies (Ab) are associated with dermatomyositis. Anti-transcription intermediary factor-1-γ/α (TIF-1-γ/α) Ab was recently identified as an auto-Ab and was observed mostly in cancer-associated dermatomyositis. IgG4-related disease is a newly described entity characterized by increased serum IgG4 levels and IgG4-positive plasma cell infiltration with fibrosis in organs such as the pancreas and parotid gland. IgG4-related disease also includes inflammatory pseudotumors in various organs. We report herein a 59-year-old Japanese man who had dermatomyositis complicated with a gastric cancer and an IgG4-related pulmonary inflammatory pseudotumor. He manifested typical classical Gottron's papules on the fingers, V-sign erythema on the chest, flagellate erythema on the back, nail fold bleeding and facial erythema. Serum levels of anti-TIF-1-γ/α Ab were positive as assessed by immunoprecipitation assay. He also had bilateral swelling of the parotid gland, and an excised specimen of the lung showed inflammatory pseudotumor with IgG4-positive plasma cells. As far as we know, this case is the first to report the association of IgG4-related disease and TIF-1-γ/α-positive dermatomyositis. Further accumulation of such cases is required to elucidate the mechanism of this association.</div></div></div></description></item></channel></rss>